FARAH ALVI: Open Payments
NPI 1316345895 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 25 payments from 8 companies in 2025. Trend: 2023 $732 · 2024 $400 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 2 | $144 |
| Collegium Pharmaceutical, Inc. | 7 | $144 |
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $87 |
| Averitas Pharma Inc. | 3 | $75 |
| Tonix Medicines, Inc. | 2 | $56 |
| Abbott Laboratories | 2 | $43 |
| ABBVIE INC. | 2 | $40 |
| Electronic Waveform Lab, Inc. | 2 | $28 |
Products named: Evoke, Belbuca, JOURNAVX, QUTENZA, TONMYA, ETERNA, QULIPTA, BOTOX.
Industry payments across MD — which companies pay providers there.
